145 related articles for article (PubMed ID: 18197855)
1. Oral lesions as predictors of highly active antiretroviral therapy failure in Brazilian HIV-infected children.
Miziara ID; Weber R
J Oral Pathol Med; 2008 Feb; 37(2):99-106. PubMed ID: 18197855
[TBL] [Abstract][Full Text] [Related]
2. Oral candidosis and oral hairy leukoplakia as predictors of HAART failure in Brazilian HIV-infected patients.
Miziara ID; Weber R
Oral Dis; 2006 Jul; 12(4):402-7. PubMed ID: 16792726
[TBL] [Abstract][Full Text] [Related]
3. Oral lesions as clinical markers of highly active antiretroviral therapy failure: a nested case-control study in Mexico City.
Ramírez-Amador V; Ponce-de-León S; Anaya-Saavedra G; Crabtree Ramírez B; Sierra-Madero J
Clin Infect Dis; 2007 Oct; 45(7):925-32. PubMed ID: 17806063
[TBL] [Abstract][Full Text] [Related]
4. Oral lesions in Brazilian HIV-infected children undergoing HAART.
Miziara ID; Filho BC; Weber R
Int J Pediatr Otorhinolaryngol; 2006 Jun; 70(6):1089-96. PubMed ID: 16406081
[TBL] [Abstract][Full Text] [Related]
5. Otitis media in Brazilian human immunodeficiency virus infected children undergoing antiretroviral therapy.
Miziara ID; Weber R; Araújo Filho BC; Pinheiro Neto CD
J Laryngol Otol; 2007 Nov; 121(11):1048-54. PubMed ID: 17319998
[TBL] [Abstract][Full Text] [Related]
6. The effect of antiretroviral therapy on the prevalence of oral manifestations in HIV-infected patients: a UK study.
Tappuni AR; Fleming GJ
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2001 Dec; 92(6):623-8. PubMed ID: 11740479
[TBL] [Abstract][Full Text] [Related]
7. Oral manifestations of HIV infection in patients receiving highly active antiretroviral therapy (HAART) in Bahia, Brazil.
da Silva CA; Dourado I; Dahia SR; Harzheim E; Rutherford GW
J Public Health Dent; 2008; 68(3):178-81. PubMed ID: 18248345
[TBL] [Abstract][Full Text] [Related]
8. Sensitivity and specificity of using CD4+ measurement and clinical evaluation to determine antiretroviral treatment failure in Thailand.
Chaiwarith R; Wachirakaphan C; Kotarathititum W; Praparatanaphan J; Sirisanthana T; Supparatpinyo K
Int J Infect Dis; 2007 Sep; 11(5):413-6. PubMed ID: 17331776
[TBL] [Abstract][Full Text] [Related]
9. Oral complication risks after invasive and non-invasive dental procedures in HIV-positive patients.
Campo J; Cano J; del Romero J; Hernando V; Rodríguez C; Bascones A
Oral Dis; 2007 Jan; 13(1):110-6. PubMed ID: 17241440
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of oral lesions and periodontal diseases in HIV-infected patients on antiretroviral therapy.
Kroidl A; Schaeben A; Oette M; Wettstein M; Herfordt A; Häussinger D
Eur J Med Res; 2005 Oct; 10(10):448-53. PubMed ID: 16287607
[TBL] [Abstract][Full Text] [Related]
11. Long-term effectiveness of highly active antiretroviral therapy on the survival of children and adolescents with HIV infection: a 10-year follow-up study.
Patel K; Hernán MA; Williams PL; Seeger JD; McIntosh K; Van Dyke RB; Seage GR;
Clin Infect Dis; 2008 Feb; 46(4):507-15. PubMed ID: 18199042
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of ocular manifestations and blindness in HIV/AIDS patients on HAART in a tertiary care hospital in western India.
Shah SU; Kerkar SP; Pazare AR
Br J Ophthalmol; 2009 Jan; 93(1):88-90. PubMed ID: 18952644
[TBL] [Abstract][Full Text] [Related]
13. Orofacial lesions in 126 newly diagnosed HIV/AIDS patients seen at the University College Hospital, Ibadan.
Okoje VN; Obiechina AE; Aken'Ova YA
Afr J Med Med Sci; 2006 Mar; 35(1):97-101. PubMed ID: 17209335
[TBL] [Abstract][Full Text] [Related]
14. Impact of hepatitis B virus co-infection on response to highly active antiretroviral treatment and outcome in HIV-infected individuals: a nationwide cohort study.
Omland LH; Weis N; Skinhøj P; Laursen A; Christensen PB; Nielsen HI; Møller A; Engsig F; Sørensen HT; Obel N
HIV Med; 2008 May; 9(5):300-6. PubMed ID: 18400077
[TBL] [Abstract][Full Text] [Related]
15. Changing patterns of buccal manifestations in AIDS.
Miziara ID; Valentini Mj; Romano FR; Miniti A
Rev Laryngol Otol Rhinol (Bord); 2002; 123(4):231-4. PubMed ID: 12723487
[TBL] [Abstract][Full Text] [Related]
16. Determinants of virological failure after successful viral load suppression in first-line highly active antiretroviral therapy.
Geretti AM; Smith C; Haberl A; Garcia-Diaz A; Nebbia G; Johnson M; Phillips A; Staszewski S
Antivir Ther; 2008; 13(7):927-36. PubMed ID: 19043927
[TBL] [Abstract][Full Text] [Related]
17. Changes in leptin serum levels in HIV-infected children receiving highly active antiretroviral therapy.
Papaevangelou V; Papassotiriou I; Vounatsou M; Chrousos G; Theodoridou M
Scand J Clin Lab Invest; 2007; 67(3):291-6. PubMed ID: 17454843
[TBL] [Abstract][Full Text] [Related]
18. Current oral manifestations of HIV infection.
Navazesh M
J Calif Dent Assoc; 2001 Feb; 29(2):137-41. PubMed ID: 11324113
[TBL] [Abstract][Full Text] [Related]
19. Trends in bacteremia in the pre- and post-highly active antiretroviral therapy era among HIV-infected children in the US Perinatal AIDS Collaborative Transmission Study (1986-2004).
Kapogiannis BG; Soe MM; Nesheim SR; Sullivan KM; Abrams E; Farley J; Palumbo P; Koenig LJ; Bulterys M
Pediatrics; 2008 May; 121(5):e1229-39. PubMed ID: 18450865
[TBL] [Abstract][Full Text] [Related]
20. Gender differences in human immunodeficiency virus-related oral lesions: an Italian study.
Campisi G; Pizzo G; Mancuso S; Margiotta V
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2001 May; 91(5):546-51. PubMed ID: 11346733
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
